ES2139568T3 - Complejo proteico. - Google Patents
Complejo proteico.Info
- Publication number
- ES2139568T3 ES2139568T3 ES90906389T ES90906389T ES2139568T3 ES 2139568 T3 ES2139568 T3 ES 2139568T3 ES 90906389 T ES90906389 T ES 90906389T ES 90906389 T ES90906389 T ES 90906389T ES 2139568 T3 ES2139568 T3 ES 2139568T3
- Authority
- ES
- Spain
- Prior art keywords
- macromolecule
- protein complex
- sperm
- assay
- purification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UNA MACROMOLECULA DE NATURALEZA PROTEINICA QUE ACTIVA LA MOVILIDAD ESPERMATICA, UN PROCESO PARA LA PREPARACION DE LA MISMA MEDIANTE PURIFICACION DE LA MACROMOLECULA DE FLUIDOS EXTRACELULARES, PREPARACIONES FARMACEUTICAS QUE CONSTAN DE LA MACROMOLECULA Y ANTICUERPOS DIRIGIDOS CONTRA ESPECIFICOS DETERMINANTES A DICHA MACROMOLECULA Y LA UTILIZACION DE LA MISMA ASI COMO UN METODO PARA ENSAYAR LA FERTILIDAD POTENCIAL DEL ESPERMA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8901127A SE8901127D0 (sv) | 1989-03-31 | 1989-03-31 | Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2139568T3 true ES2139568T3 (es) | 2000-02-16 |
Family
ID=20375510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90906389T Expired - Lifetime ES2139568T3 (es) | 1989-03-31 | 1990-04-02 | Complejo proteico. |
Country Status (10)
Country | Link |
---|---|
US (2) | US5304464A (es) |
EP (2) | EP0965595A1 (es) |
JP (1) | JP2886979B2 (es) |
AT (1) | ATE185150T1 (es) |
AU (1) | AU635258B2 (es) |
DE (1) | DE69033306T2 (es) |
DK (1) | DK0474645T3 (es) |
ES (1) | ES2139568T3 (es) |
SE (1) | SE8901127D0 (es) |
WO (1) | WO1990012032A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5844097A (en) * | 1990-11-30 | 1998-12-01 | Monoclonetics International, Inc. | Methods for the diagnosis of peripheral nerve damage |
ATE132269T1 (de) * | 1990-11-30 | 1996-01-15 | Monoclonetics Int | Verfahren zur diagnose chronischer niedriger rückenschmerzen und nackenschmerzen |
EP0948343B1 (en) * | 1996-11-21 | 2006-02-08 | Promega Corporation | Alkyl peptide amides adapted for topical administration |
EP0939085A1 (en) | 1998-02-26 | 1999-09-01 | Council of Scientific and Industrial Research | A process for the purification of a motility-promoting protein from buffalo serum |
WO2005051413A2 (en) * | 2003-11-26 | 2005-06-09 | Novartis Ag | Disease associated genes |
EP2997823B1 (en) | 2014-09-19 | 2017-12-20 | Instruments Utils de Laboratori Geniul, SL | Procedure to improve sperm quality in mammals |
CN107998397B (zh) * | 2017-12-07 | 2020-09-04 | 复旦大学附属华山医院 | Emc10蛋白作为生物标志物在诊断男性不育中的应用 |
JP7360008B2 (ja) | 2019-03-22 | 2023-10-12 | 日亜化学工業株式会社 | 精子の運動能力を増加させる方法及び装置 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4339434A (en) * | 1981-08-17 | 1982-07-13 | Gametrics Limited | Method of increasing the incidence of female offspring |
US4511558A (en) * | 1983-05-16 | 1985-04-16 | University Patents, Inc. | Alpha-lactalbumin contraceptive |
SE449003B (sv) * | 1985-10-18 | 1987-03-30 | Pharmacia Ab | Sett att in vitro avskilja spermier med egen rorelseformaga medelst penetrationsmedium i vilket ingar hyaluronsyrasalt |
US4765972A (en) * | 1986-04-03 | 1988-08-23 | The United States Of America As Represented By The Department Of Health And Human Services | Vinca alkaloid photoactive analogs and their uses |
US5059680A (en) * | 1986-11-24 | 1991-10-22 | Centocor, Inc. | Method of isolating ca 125 antigen |
US5166190A (en) * | 1990-01-08 | 1992-11-24 | Genentech, Inc. | Method for increasing fertility in males |
-
1989
- 1989-03-31 SE SE8901127A patent/SE8901127D0/xx unknown
-
1990
- 1990-04-02 DE DE69033306T patent/DE69033306T2/de not_active Expired - Fee Related
- 1990-04-02 US US07/777,277 patent/US5304464A/en not_active Expired - Lifetime
- 1990-04-02 EP EP99105954A patent/EP0965595A1/en not_active Withdrawn
- 1990-04-02 WO PCT/SE1990/000213 patent/WO1990012032A1/en active IP Right Grant
- 1990-04-02 AT AT90906389T patent/ATE185150T1/de not_active IP Right Cessation
- 1990-04-02 EP EP90906389A patent/EP0474645B1/en not_active Expired - Lifetime
- 1990-04-02 JP JP2506056A patent/JP2886979B2/ja not_active Expired - Fee Related
- 1990-04-02 DK DK90906389T patent/DK0474645T3/da active
- 1990-04-02 ES ES90906389T patent/ES2139568T3/es not_active Expired - Lifetime
- 1990-04-02 AU AU54318/90A patent/AU635258B2/en not_active Ceased
-
1993
- 1993-08-18 US US08/108,000 patent/US5453354A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU635258B2 (en) | 1993-03-18 |
JPH04505614A (ja) | 1992-10-01 |
DK0474645T3 (da) | 2000-03-27 |
EP0474645A1 (en) | 1992-03-18 |
ATE185150T1 (de) | 1999-10-15 |
EP0965595A1 (en) | 1999-12-22 |
AU5431890A (en) | 1990-11-05 |
DE69033306T2 (de) | 2000-04-13 |
US5453354A (en) | 1995-09-26 |
WO1990012032A1 (en) | 1990-10-18 |
EP0474645B1 (en) | 1999-09-29 |
JP2886979B2 (ja) | 1999-04-26 |
US5304464A (en) | 1994-04-19 |
DE69033306D1 (de) | 1999-11-04 |
SE8901127D0 (sv) | 1989-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU49370B (sh) | Postupak za pripremanje vakcine protiv lajmske bolesti | |
DK614987A (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
NO961115D0 (no) | Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser | |
EP0683234A4 (en) | ANTIBODIES DIRECTED AGAINST -g (b) -AMYLOID OR A DERIVATIVE THEREOF AND ITS USE. | |
ATE150319T1 (de) | Behandlung von asthma | |
FI913943A0 (fi) | Nya kroman- och tiokromanderivat. | |
ATE263836T1 (de) | Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür | |
DE122005000035I1 (de) | Verfahren zur Reinigung von waessrigen Extrakten, die allergenische Proteine enthalten, so erhalteneExtrakte und ihre Verwendung. | |
DE69033306D1 (de) | Proteinkomplex | |
ATE151078T1 (de) | Verfahren und zwischenprodukte synthetischer antikörperderivate | |
ES2042461T1 (es) | Producto y procedimiento para el te\ido oxidativo del cabello. | |
PT85317A (fr) | Procede pour l:obtention d:imunotoxines par couplage d:un anticorps avec une proteine trichosanthine ou trickokirine | |
DK0585570T3 (da) | Granulocytbindende antistofkonstrukter, deres fremstilling og anvendelse | |
DE69311796D1 (de) | Peptide von dem caseinomacropeptid, antikorper dagegen und ihre andwendungen | |
ATE124706T1 (de) | Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben. | |
MY131433A (en) | Novel metazoan parasite antigens having pepstatin binding activity and their use in vaccines | |
FR2571146B1 (fr) | Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant | |
PT88913A (pt) | Processo para a preparacao da proteina pp4-x anticoagulante | |
FR2559157B1 (fr) | Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent | |
ES2056844T3 (es) | Antigeno de treponema hyodysenteriae y sus usos. | |
PT998493E (pt) | Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos | |
DE69008859D1 (de) | Modifizierte menschliche anti-rh(d)-antikörper. | |
ATE110786T1 (de) | Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa. | |
ES2060162T3 (es) | Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina. | |
ES2076238T3 (es) | Adnc que codifica la proteina 9 de placenta (pp9), su aislamiento y utilizacion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 474645 Country of ref document: ES |